JPMorgan Chase & Co  $124.91

AbbVie, Inc. is a biopharmaceutical company based in North Chicago, Illinois, with a focus on research and the sale of pharmaceutical products. The company has a workforce of 50,000 full-time employees and went public on 2013-01-02 with an IPO launch. AbbVie's range of therapeutic categories includes immunology products like Humira, Skyrizi, and Rinvoq, oncology products such as Imbruvica and Venclexta, aesthetics products like Botox Cosmetic and Juvederm Collection, neuroscience products such as Botox Therapeutic, Vraylar, Duopa, and Duodopa, and Ubrelvy, eye care products consisting of Lumigan, Alphagan, and Restasis, women's health products including Lo Loestrin, Orilissa, and others, and other products such as Mavyret, Creon, Lupron, Linzess, and Synthroid. AbbVie sells its products to wholesalers, government agencies, healthcare facilities, and independent retailers. In addition to selling products, AbbVie also develops and discovers antibody medicines that target difficult-to-drug disease-causing proteins like G protein-coupled receptors (GPCRs). Stay updated with AbbVie's stock price today and premarket information, including shares and market cap, for informed investment decisions.